Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through ?-catenin

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1478-811X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through ?-catenin ; volume:12 ; number:1 ; day:25 ; month:10 ; year:2014 ; pages:1-15 ; date:12.2014
Cell communication and signaling ; 12, Heft 1 (25.10.2014), 1-15, 12.2014

Creator: Shang, Xiying

Contributor: Lin, Xinjian
Howell, Stephen B.
SpringerLink (Online service)

DOI: 10.1186/s12964-014-0059-5

URN: urn:nbn:de:1111-201607267606

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 2025-08-14T10:57:43+0200

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Shang, Xiying
Lin, Xinjian
Howell, Stephen B.
SpringerLink (Online service)

Other Objects (12)

β-Catenin: oncogenic role and therapeutic target in cervical cancer

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors

Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling

BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity

Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers

The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer

Claudin-7 deficiency promotes stemness properties in colorectal cancer through Sox9-mediated Wnt/β-catenin signalling

Regulatory chromatin rewiring promotes metabolic switching during adaptation to oncogenic receptor tyrosine kinase inhibition

Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes

RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma

Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers

Hochschulschrift

Functional analyses of oncogenic CARMA1 mutants reveal a crosstalk between NF-kB [NF-kappa] and β-Catenin [Beta-Catenin] in lymphoma

β-Catenin: oncogenic role and therapeutic target in cervical cancer

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors

Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling

BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity

Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers

The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer

Claudin-7 deficiency promotes stemness properties in colorectal cancer through Sox9-mediated Wnt/β-catenin signalling

Regulatory chromatin rewiring promotes metabolic switching during adaptation to oncogenic receptor tyrosine kinase inhibition

Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes

RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma

Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers

Hochschulschrift

Functional analyses of oncogenic CARMA1 mutants reveal a crosstalk between NF-kB [NF-kappa] and β-Catenin [Beta-Catenin] in lymphoma

β-Catenin: oncogenic role and therapeutic target in cervical cancer

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors

Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling

BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity

Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers

The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer

Claudin-7 deficiency promotes stemness properties in colorectal cancer through Sox9-mediated Wnt/β-catenin signalling

Regulatory chromatin rewiring promotes metabolic switching during adaptation to oncogenic receptor tyrosine kinase inhibition

Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes

RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma

Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers

Hochschulschrift

Functional analyses of oncogenic CARMA1 mutants reveal a crosstalk between NF-kB [NF-kappa] and β-Catenin [Beta-Catenin] in lymphoma

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through ?-catenin

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

β-Catenin: oncogenic role and therapeutic target in cervical cancer

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors

Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling

BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity

Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers

The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer

Claudin-7 deficiency promotes stemness properties in colorectal cancer through Sox9-mediated Wnt/β-catenin signalling

Regulatory chromatin rewiring promotes metabolic switching during adaptation to oncogenic receptor tyrosine kinase inhibition

Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes

RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma

Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers

Functional analyses of oncogenic CARMA1 mutants reveal a crosstalk between NF-kB [NF-kappa] and β-Catenin [Beta-Catenin] in lymphoma

β-Catenin: oncogenic role and therapeutic target in cervical cancer

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors

Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling

BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity

Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers

The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer

Claudin-7 deficiency promotes stemness properties in colorectal cancer through Sox9-mediated Wnt/β-catenin signalling

Regulatory chromatin rewiring promotes metabolic switching during adaptation to oncogenic receptor tyrosine kinase inhibition

Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes

RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma

Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers

Functional analyses of oncogenic CARMA1 mutants reveal a crosstalk between NF-kB [NF-kappa] and β-Catenin [Beta-Catenin] in lymphoma

β-Catenin: oncogenic role and therapeutic target in cervical cancer

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors

Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling

BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity

Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers

The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer

Claudin-7 deficiency promotes stemness properties in colorectal cancer through Sox9-mediated Wnt/β-catenin signalling

Regulatory chromatin rewiring promotes metabolic switching during adaptation to oncogenic receptor tyrosine kinase inhibition

Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes

RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma

Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers

Functional analyses of oncogenic CARMA1 mutants reveal a crosstalk between NF-kB [NF-kappa] and β-Catenin [Beta-Catenin] in lymphoma

Related objects

Reset password